शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSEMICROSE INDIA LTD.· FinanceLowNeutral
Announced Thu, 29 Oct, 2026 · 14:43 IST

Board meeting set for November 4, 2026

Net loss reportedNegative operating cash flowDebt to equity above the thresholdResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

The board will consider the company’s unaudited standalone results for the quarter and six months ended September 30, 2026, along with a limited review report from the statutory auditors. Trading by designated persons and their relatives has been closed since October 1 until 48 hours after the results are announced. No financial figures are provided.

Likely market impact

No performance numbers are disclosed yet. The stock may react when the results are announced on November 4, 2026.

By the numbersStandalone · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹0.00 Cr−₹0.02 Crloss narrowed
Operating profit−₹0.03 Cr−₹0.09 Crloss narrowed
Profit after tax−₹0.03 Cr−₹0.09 Crloss narrowed
EBITDA margin———

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.